CASP3 and neoplasm: Additionally, the anti-breast cancer effect was further validated in an MDA-MB-231 breast tumor mouse model, where mice treated with DOX-ARPI/CS NPs had the smallest tumor volume, highest caspase-3 expression, and longest survival time.